{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1101/2020.10.05.327015",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/nap-cnb",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3170"
        },
        {
          "@id": "edam:topic_3474"
        },
        {
          "@id": "edam:topic_3930"
        },
        {
          "@id": "edam:topic_0769"
        },
        {
          "@id": "edam:topic_0154"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/2020.10.05.327015"
      },
      "sc:description": "Bioinformatic pipeline to predict MHC-I-restricted T cell epitopes in mice.\n\nNeoAntigens Prediction @ CNB (NAP-CNB) is a agent for the prediction of neoantigenic peptides from tumoral RNA-seq or peptide sequences. NAP-CNB uses variant calling methods with models trained on recurrent neuronal networks (RNN) to produce a list of putative neoantigens.",
      "sc:featureList": [
        {
          "@id": "edam:operation_3927"
        },
        {
          "@id": "edam:operation_0252"
        },
        {
          "@id": "edam:operation_3227"
        }
      ],
      "sc:name": "NAP-CNB",
      "sc:url": "http://biocomp.cnb.csic.es/NeoantigensApp/"
    }
  ]
}